CD248 and non-small cell lung carcinoma: Based on these functional investigations, CD248 modulated the nuclear factor kappa B (NF‐κB) axis to enhance the CAFs‐mediated release of IL‐8, which resulted in NSCLC cisplatin resistance, and additionally, activated NF‐κB and up‐regulated ATP‐binding cassette transporter B1 (ABCB1) expression.